Background Leishmania coinfection is frequently seen in human immunodeficiency virus (HIV)-infected patients in endemic areas, and from time to time the protozoan is detected in cutaneous biopsies.
Introduction
Leishmaniasis, caused by a protozoan of the genus Leishmania , includes a series of diseases which vary widely depending on the infecting species, the reservoir, the transmitting agent and the susceptibility of the host. 1 Spanish dermatologists, especially in certain Mediterranean areas, quite often see children with the cutaneous form of leishmaniasis, generally caused by Leishmania tropica minor , and in which Phlebotomus papatasi acts as the vector. However, despite the fact that visceral leishmaniasis, usually caused by L. donovani or L. infantum , is also endemic in this area, cutaneous manifestations are rare, and are most often associated with non-specific eruptions during the acute phase, showing macular lesions and dischromatic, erythematous or nodular lesions of postkala-azar dermal leishmaniasis. 2 In a 9-year period we have detected the histopathological presence of Leishmania in various cutaneous biopsies from human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis. Although its presence does not imply that it is the cause of the dermatological process, we feel it is necessary to establish criteria to determine whether Leishmania is responsible for the disease. Current ease of travel requires specialists working outside endemic areas to be aware of these infections and their presentations.
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Patients and methods
Nine HIV-positive patients, seven men and two women, with different degrees of immunosuppression (Table 1) 
Results
The presence of Leishmania in the dermis was considered responsible for the processes leading to the biopsy of the cutaneous alterations of patients 1-4 and the extensive infiltrated plaques of patient 5. The facial itching hyperpigmentation in patient 1 disappeared with antiprotozoan treatment, whereas it persisted with systemic antihistamine derivatives and topical steroids. The evolutionary correlation with visceral leishmaniasis was especially evident in patient 2, in whom the appearance of infiltration over a tattoo ( Fig. 1 ) was simultaneous with hematological involvement. This same patient later developed an itching papulo-erythematous eruption ( Fig. 2) , in which leishmanias were also detected whereas no leishmanias were found in a biopsy of nearby unaltered skin taken at the same time. This same situation, with pruritus and top-flattened papules, also occurred in patient 3. The presence of a greater degree of infiltration was more obvious in patient 4, with the presentation of disseminated papules, and even more obvious in patient 5, who showed large infiltrated plaques (Fig. 3) . The last two patients also had intense pruritus. In contrast, in the indurated nodule of patient 5 and the cutaneous disorders of patients 6 -9, the presence of Leishmania was considered a chance biopsy finding, and Leishmania was not therefore considered to be the cause of the cutaneous process for which the patients had originally consulted. This conclusion was reached after the clinical, analytical, and pathological demonstration of another disorder responsible for the manifestations, after the detection of leishmanias in areas of non-affected skin, or after verifying independence to antileishmanial therapy. The presence of protozoa was detected in cutaneous lesions associated with Reiter's syndrome, cryptococcosis, bacillary angiomatosis, psoriasis or oral aphthae and in a dermatofibroma which had been removed to rule out the possibility of Kaposi's sarcoma. Of note in the pathological examination was the existence in most sections of a large number of leishmanias, both intracellularly and extracellularly, clearly visible even with the usual hematoxilin-eosin stain (Fig. 4) . In those cases attributable to the presence of leishmanias, the histological features ranged from scarce lymphohistiocytic infiltrate, via the presentation of dermal granulomas, to the existence of a massive infiltration of histiocytes laden with leishmanias which only respected a narrow band of collagen in the superficial dermis (Fig. 5) . In six cases the lymphohistiocytic infiltrate with leishmanias coexisted with histopathological changes typical of other processes, on occasions as characteristic as those of bacillary angiomatosis or the striking presence of spores of Cryptococcus neoformans .
After dermatological study and clinical and hematological evaluation of the patient, therapy was initiated on nine occasions, seven with antimonial compounds (cases 1, 2, 3, 5, 6, 8 and 11), and two with liposomal amphotericin B (cases 4 and 9). The response to these treatments was important for establishing or discarding the causal role of Leishmania . Two patients (6 and 8) treated with antimonial compounds died. 4 Presence of large amounts of leishmanias in the biopsy, which is usual in these patients, enabling them to be seen easily with a hematoxilin-eosin stain Some role of cardiac side-effects of these drugs in conjunction with other alterations was suspected, but the actual cause could not be determined as permission for autopsy was not granted.
Discussion
Over recent years, the natural immune response has been altered in many patients by the action of HIV. Although the repercussions for cutaneous and mucocutaneous leishmaniasis have not been great, several reports have appeared of unusual forms of these diseases in HIV-positive patients. [5] [6] [7] [8] [9] [10] [11] [12] [13] In contrast, in countries around the Mediterranean basin, including Spain, where the infection is endemic, there is a high prevalence of visceral ("kala-azar") leishmaniasis among HIVpositive patients, [14] [15] [16] [17] [18] with an estimated 1-3% of these patients being infected. 19 In fact, although leishmaniasis is not at present included among the definitive criteria for acquired immunodeficiency syndrome (AIDS), its inclusion has been proposed. [20] [21] [22] [23] This high prevalence is mainly a result of reactivation of a latent infection by immunosuppression, with antileishmania serology tests and CD4+ T-cell counts being proposed for its prophylactic and therapeutic control. 24, 25 The influence of immunosuppression is also supported by the frequent treatment failures in these patients and by the reduction of these observations over recent years, since the use of antiretroviral therapy has prevented situations of severe immunosuppression. The predominance of intravenous drug abusers among our patients is the result of intravenous drug abuse being the most common risk factor in our area, although the possibility has also been suggested that these patients act as reserves for transmission by contaminated needles. 26, 27 Paralleling the increase in cases of visceral leishmnaisis in HIV-positive patients are reports of different cutaneous manifestations in which leishmanias have been detected, though the etiologic and pathogenic significance of this finding with regard to cutaneous manifestations may be different, as we suggested in our initial report some years ago. 28 Occasionally, the presence of protozoa in dermal histiocytes is attributable solely to the existence of a general impregnation of the macrophagocytic system, which is especially intense in immunosuppressed patients. The detection therefore of cutaneous amastigotes in a patient with visceral leishmaniasis does not necessarily imply that they are the cause of the dermatological process under study. Leishmanias have been noted in healthy skin 29 as well as in lesions from widely different processes including Kaposi's sarcoma, [30] [31] [32] [33] herpes simplex and zoster, 34, 35 and a dermatofibroma. 36 From our cases, it is possible to include within this group the clinically and histopathologically typical psoriasis and the erythematous desquamative eruption seen in a typical case of Reiter's syndrome. Moreover, their coexistence with the infectious agents responsible for bacillary angiomatosis and cryptococcosis, which has not previously been reported, was clear. Finally, they were also detected in a dermatofibroma and in an ulcerated lesion of the oral mucosa, which from its evolution and features was an oral aphtha. In two cases this incidental observation led to the diagnosis of an unsuspected visceral leishmaniasis, which in the absence of clinical and hematological data should be confirmed by bone marrow study, including cultures in adequate media.
Although not mentioned in comparative studies, 37 cutaneous involvement during the course of visceral leishmaniasis seems to be more frequent in HIV-positive patients than in immunocompetent persons. Manifestations reported comprise a wide range of changes, such as hyperpigmented lesions, which gave rise to the term "kala-azar" (black fever) in one of the languages of India, and diverse papular and nodular eruptions, more or less extensive and florid, which indicate the involvement or persistence of cutaneous leishmanias. [38] [39] [40] [41] [42] Other manifestations with varying clinical aspects have also been reported, including erythroderma, dermatomyositis and psoriasis. [43] [44] [45] Our experience confirms this great clinical and pathological variability. The presence of infiltration over a tattoo has been reported previously 36 and in our case it is gaudy, the infiltrative relapses coinciding with systemic worsening.
Of note in three of the patients (cases 3, 4 and 5) was the papular eruption, mainly involving the extremities, with certain clinical features resembling lichen planus. An important clinical detail, also present in another two of the six cases, attributable to the presence of leishmanias was the intense pruritus accompanying the lesions. This symptom may well be of use when considering the possibility of visceral leishmaniasis as an explanation for these specific cutaneous manifestations. At no time did we see any lesions in the oral mucosa, which could have been considered attributable to the direct activity of Leishmania , although this has been reported on occasion. 27, [46] [47] [48] The histopathological findings in cutaneous lesions are variable and often atypical, 42, 49 as in other organs. 50 Of interest in our series, together with the non-specific images and variable granulomatous appearance, was the case with an intense histiocytic infiltrate laden with leishmanias respecting a narrow band in the superficial dermis, similar to that seen in lepromatous leprosy. Its coincidence with severe immunosuppression confirms it as an anergic form and suggests the existence in leishmaniasis of a similar situation to leprosy, with clinical and pathological differences depending on the immune response.
The large amount of leishmanias present in most cases enabled them to be seen easily with routine stains, and emphasizes the importance of the histopathological study of these lesions. In fact, it led to the diagnosis of clinically non-specific lesions, and on two occasions resulted in the diagnosis of a previously unsuspected visceral leishmaniasis. The demonstration of leishmanias is essential but, as we have seen, does not necessarily indicate that they have a causal role in the lesions under study. It is necessary to discard other processes and, more especially, to demonstrate a good evolutionary correlation with the systemic symptoms and with the response to antiprotozoan therapy.
Seven of the nine patients in which leishmanias were detected had lymphocyte counts ≤ 250 CD4/mm 3 , many of these corresponding to the period prior to the introduction of multiple antiretroviral therapy, when situations of severe immunosuppression were common. At that time the HIV viral load was not determined, but later studies showed the existence of a relationship between this and the quantification of leishmanias in bone marrow, as well as their influence in the response to antileishmanial therapy. 51 The tendency of the infection to persist is demonstrated by the fact that eight of the cases in which leishmanias were detected arose in patients who had previously received antimonial or liposomal amphotericin B treatment. The prognosis in these patients is uncertain, so they should undergo close follow-up and be given secondary prophylaxis 52 at least until there is a clear improvement in their immune status. 53 
